Sphera Funds Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-159,323
| Closed | -$2.84M | – | 135 |
|
|
2025
Q2 | $2.72M | Buy |
159,323
+1,392
| +0.9% | +$59.4K | 0.64% | 53 |
|
|
2025
Q1 | $10.1M | Buy |
157,931
+59,010
| +60% | +$6.21M | 2.32% | 8 |
|
|
2024
Q4 | $12M | Sell |
98,921
-26,925
| -21% | -$3.3M | 2.17% | 9 |
|
|
2024
Q3 | $15.7M | Buy |
125,846
+42,187
| +50% | +$5.83M | 2.5% | 7 |
|
|
2024
Q2 | $13.2M | Buy |
83,659
+28,045
| +50% | +$3.6M | 1.8% | 12 |
|
|
2024
Q1 | $7.2M | Buy |
55,614
+43,114
| +345% | +$5.28M | 1.01% | 34 |
|
|
2023
Q4 | $1.21M | Sell |
12,500
-37,500
| -75% | -$3.6M | 0.19% | 83 |
|
|
2023
Q3 | $6.06M | Hold |
50,000
| – | – | 1.1% | 34 |
|
|
2023
Q2 | $5.73M | Buy |
50,000
+6,000
| +14% | +$774K | 0.89% | 45 |
|
|
2023
Q1 | $6.06M | Buy |
+44,000
| New | +$5.71M | 1.01% | 32 |
|
|
2021
Q1 | – | Sell |
-75,000
| Closed | -$12.8M | – | 199 |
|
|
2020
Q4 | $12.8M | Sell |
75,000
-96,500
| -56% | -$14.3M | 1.13% | 20 |
|
|
2020
Q3 | $24.1M | Buy |
171,500
+48,300
| +39% | +$7.34M | 2.37% | 10 |
|
|
2020
Q2 | $19.8M | Sell |
123,200
-134,800
| -52% | -$18.3M | 1.86% | 14 |
|
|
2020
Q1 | $25.2M | Buy |
258,000
+118,000
| +84% | +$13.5M | 3.16% | 10 |
|
|
2019
Q4 | $18.1M | Sell |
140,000
-108,038
| -44% | -$10.9M | 1.49% | 13 |
|
|
2019
Q3 | $18.7M | Buy |
248,038
+203,038
| +451% | +$24M | 2.89% | 9 |
|
|
2019
Q2 | $6.84M | Sell |
45,000
-28,405
| -39% | -$3.45M | 0.94% | 33 |
|
|
2019
Q1 | $8.75M | Sell |
73,405
-43,112
| -37% | -$5.54M | 0.8% | 23 |
|
|
2018
Q4 | $12.7M | Buy |
116,517
+40,401
| +53% | +$5.05M | 1.43% | 17 |
|
|
2018
Q3 | $12.3M | Sell |
76,116
-68,980
| -48% | -$9.43M | 1.41% | 14 |
|
|
2018
Q2 | $19.2M | Sell |
145,096
-103,901
| -42% | -$9.8M | 2.64% | 10 |
|
|
2018
Q1 | $18.4M | Sell |
248,997
-136,000
| -35% | -$9.07M | 2.8% | 9 |
|
|
2017
Q4 | $21.4M | Hold |
384,997
| – | – | 2.51% | 7 |
|
|
2017
Q3 | $17.5M | Buy |
384,997
+1,950
| +0.5% | +$77.9K | 2.49% | 7 |
|
|
2017
Q2 | $12.9M | Sell |
383,047
-100,000
| -21% | -$3.26M | 2.19% | 12 |
|
|
2017
Q1 | $14.3M | Buy |
483,047
+85,000
| +21% | +$2.63M | 2.8% | 9 |
|
|
2016
Q4 | $10.9M | Buy |
398,047
+135,000
| +51% | +$5.42M | 2.76% | 9 |
|
|
2016
Q3 | $16.2M | Buy |
+263,047
| New | +$7.95M | 2.63% | 5 |
|
|
2015
Q4 | – | Sell |
-55,000
| Closed | -$1.77M | – | 133 |
|
|
2015
Q3 | $1.77M | Sell |
55,000
-95,000
| -63% | -$3.22M | 0.23% | 100 |
|
|
2015
Q2 | $4.57M | Buy |
+150,000
| New | +$3.07M | 0.45% | 48 |
|
|
2015
Q1 | – | Sell |
-175,000
| Closed | -$2.53M | – | 164 |
|
|
2014
Q4 | $2.53M | Buy |
+175,000
| New | +$2.96M | 0.43% | 78 |
|
|
2014
Q1 | – | Sell |
-80,000
| Closed | -$1.63M | – | 136 |
|
|
2013
Q4 | $1.63M | Buy |
+80,000
| New | +$2.38M | 0.45% | 59 |
|
Other funds holding SRPT
EAM
Sphera Funds Management's SRPT Position: Q3 2025 in Review
Sphera Funds Management sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 159,323 shares — an estimated $2.84M sold.
Sphera Funds Management first reported a position in SRPT in Q4 2013 and held it in 32 quarters. The position peaked at $25.2M in Q1 2020. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.
- Sphera Funds Management reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
- Sphera Funds Management sold 159,323 Sarepta Therapeutics shares in Q3 2025, an estimated $2.84M.
- Sphera Funds Management first reported a position in Sarepta Therapeutics in Q4 2013 and held it in 32 quarters.
- Sphera Funds Management's Sarepta Therapeutics position peaked at $25.2M in Q1 2020.
- 320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.
Based on Sphera Funds Management's 13F filing for Q3 2025, filed 14 Nov 2025.